KBI Biopharma
Presence
JSR is one of the...
JSR is a company listed under the stock ticker 4185 (JP).
JSR has a direct presence in 2 countries.JSR has 4 subsidiaries including Crown Bioscience, Inpria and JSR Life Sciences.
They are in:
- Biotechnology60%
- Chemicals20%
- Other20%
Executives
View the org chart displaying its 16 main executives
Most searched biographies at KBI Biopharma
- J.D. Mowery, Chief Executive Officer
- Marykay Marchigiani, Chief Financial Officer
- Glenn Barbrey, Senior Vice President, Quality and Regulatory
Popular executive movements at KBI Biopharma
- Jean-Baptiste Agnus has joined the company as Chief Business Officer (posted on April 16 2024).
- Peter Carbone has joined the company as Chief Quality Officer (posted on April 2 2024).
- Maggie Chen has joined the company as Senior Vice President and Site Head of Patriot Park Mammalian Good Manufacturing Practice Facility (posted on December 6 2023).
Popular executive movements at JSR
- Kazuo Ushida, Outside Director, has left the company (posted on May 8 2024).
- Seiji Takahashi, Director, Managing Officer, Manufacturing and Technology, Procurement and Logistics, has left the company (posted on May 8 2024).
- Ichiko Tachibana, Director, Senior Officer, Sustainability Promotion and Diversity Promotion, has left the company (posted on May 8 2024).
Click here to view some more movements at JSR
Create your alert
to follow the executive moves at KBI Biopharma.
Biotechnology
JSR has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by KBI Biopharma
- KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
- KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
- KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards
- KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions
- KBI Biopharma, Inc. Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP Manufacturing Facility
- KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
- KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments
- KBI's Leadership Team Discusses Operational Consolidation with Selexis at BIO International 2023
- KBI's Aaron Pilling Discusses the KBI PUREplatform Launch at BIO International 2023
- JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners
- View more press releases Close
Social media about KBI Biopharma
- KBI Biopharma on Wikipedia, Google News & Yahoo Finance
- KBI Biopharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Marykay Marchigiani 
Call KBI Biopharma at +1 919...
